The BBSRC-STFC DeepTech Catalyst Bio 2026 grant supports UK biotech start-ups advancing bioscience innovations with R&D funding, technical support, and access to UKRI research campuses.
Funder: UK Research and Innovation
Due Dates: June 26, 2026 (EOI tranche 1) | July 17, 2026 (EOI tranche 2) | August 16, 2026 (EOI tranche 3 - final) | September 14, 2026 (Full application)
Funding Amounts: Up to £50,000 R&D funding plus £10,000 innovation voucher per award; additional business and technical support included.
Summary: Supports UK early-stage biotech start-ups with funding, business support, and access to UKRI campuses to accelerate bioscience innovations.
Key Information: Applicants must have prior UKRI/Innovate UK funding or accelerator support; only one EOI per company.
The BBSRC-STFC DeepTech Catalyst Bio 2026 is a business incubator programme designed to help early-stage biotechnology start-ups in the UK achieve commercial success. Delivered by UKRI’s BBSRC and STFC, the programme offers a comprehensive support package, including direct R&D funding, innovation vouchers, business coaching, technical and IP support, and access to UKRI campuses and networks. The initiative is targeted at start-ups leveraging bioscience innovations that address clear market opportunities and are building on previous UKRI, Innovate UK, or UKRI-supported accelerator funding.